Average Co-Inventor Count = 1.55
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Revivicor, Inc. (12 from 13 patents)
12 patents:
1. 11179496 - Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
2. 11172658 - Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase
3. 11085054 - Ungulates with genetically modified immune systems
4. 10912863 - Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
5. 10383317 - Multi-transgenic pigs for diabetes treatment
6. 10300112 - Transgenic ungulates expressing CTLA4-IG and uses thereof
7. 10149461 - Immunocompromised ungulates
8. 10130737 - Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
9. 9585374 - Ungulates with genetically modified immune systems
10. 9339519 - Multi-transgenic pigs for diabetes treatment
11. 8106251 - Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
12. 7795493 - Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase